NCT04046094View on ClinicalTrials.gov

Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

September 12, 2022

Study Completion Date

August 31, 2026

Conditions
Bladder Cancer
Interventions
DRUG

Ascorbic Acid

Ascorbic Acid Intravenous

Trial Locations (3)

66160

The University of Kansas Medical Center, Kansas City

66205

The University of Kansas Cancer Center (KUCC), Fairway

The University of Kansas Cancer Center, Westwood Campus, Kansas City

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Kansas Medical Center

OTHER